GSK3B and hepatocellular carcinoma: β-catenin-370aa competitively interacts with glycogen synthase kinase 3β (GSK3β) and acts as a decoy, antagonizing GSK3β-induced β-catenin phosphorylation and degradation to stabilize full-length β-catenin, thereby activating the Wnt/β-catenin pathway to promote the malignant phenotypes of HCC (59).